Colombo P, Passini E, Re T, Faglia G, Ambrosi B
Istituto di Scienze Endocrine, Università di Milano, Ospedale Maggiore IRCCS, Italy.
Clin Endocrinol (Oxf). 1997 Jun;46(6):661-8. doi: 10.1046/j.1365-2265.1997.1330954.x.
To assess the ability of desmopressin administration to stimulate ACTH/cortisol secretion in patients with Cushing's disease, either before or after surgery, and in patients with other states characterized by ACTH hypersecretion, and to compare the results with those obtained after CRH testing.
Plasma ACTH and serum cortisol levels were evaluated after the administration of desmopressin (10 micrograms i.v.), CRH (1 microgram/kg i.v.) and saline on different days in 17 patients with Cushing's disease, 1 with occult ectopic ACTH syndrome, 5 with Addison's disease, 3 who had been bilaterally adrenalectomized for Cushing's syndrome and 4 normal subjects. After pituitary adenomectomy desmopressin and CRH were administered again to 13 of the patients who had undergone pituitary surgery for their Cushing's disease.
In 16 patients with Cushing's disease with microadenoma a positive ACTH/cortisol rise occurred in 11 patients after both desmopressin and CRH, 2 other patients were responsive only to desmopressin and 2 only to CRH, while in 1 patient equivocal responses to both tests were found. The persistence of a hormonal response to desmopressin after pituitary adenomectomy for Cushing's disease correlated with unsuccessful surgery, while, contrary to CRH, absent ACTH/cortisol rises were found in cured patients 1 and 12 months after operation. In 1 patient suspected for ectopic ACTH hypersecretion, desmopressin and CRH administration did not cause any ACTH/cortisol rise. Significant ACTH rises occurred after both desmopressin and CRH testing in patients with Addison's disease. All the 3 patients adrenalectomized for Cushing's syndrome showed a rise of ACTH levels after CRH, while a similar response after desmopressin occurred in only one of them.
Desmopressin is able to stimulate ACTH and hence cortisol release in Cushing's disease. It may be a useful test in patients with doubtful responses to CRH test, in those exhibiting responses to CRH indistinguishable from those of normal subjects and in the postoperative follow-up of Cushing's disease. In some patients with abolished or reduced cortisol feed-back at hypothalamic-pituitary level the sensitivity of normal corticotrophs to desmopressin is enhanced.
评估去氨加压素给药对库欣病患者(手术前或手术后)以及其他以促肾上腺皮质激素(ACTH)分泌过多为特征的患者中ACTH/皮质醇分泌的刺激能力,并将结果与促肾上腺皮质激素释放激素(CRH)试验后的结果进行比较。
在不同日期,对17例库欣病患者(其中1例为隐匿性异位ACTH综合征)、5例艾迪生病患者、3例因库欣综合征接受双侧肾上腺切除术的患者以及4名正常受试者静脉注射去氨加压素(10微克)、CRH(1微克/千克)和生理盐水后,评估血浆ACTH和血清皮质醇水平。对13例因库欣病接受垂体手术的患者,在垂体腺瘤切除术后再次给予去氨加压素和CRH。
在16例患有微腺瘤的库欣病患者中,11例患者在给予去氨加压素和CRH后ACTH/皮质醇均出现阳性升高,另外2例患者仅对去氨加压素反应,2例仅对CRH反应,而1例患者对两种试验均有不明确反应。库欣病患者垂体腺瘤切除术后对去氨加压素的激素反应持续存在与手术未成功相关,而与CRH相反,术后1个月和12个月治愈的患者未出现ACTH/皮质醇升高。在1例疑似异位ACTH分泌过多的患者中,给予去氨加压素和CRH后未引起任何ACTH/皮质醇升高。艾迪生病患者在给予去氨加压素和CRH试验后均出现显著的ACTH升高。所有3例因库欣综合征接受肾上腺切除术的患者在给予CRH后ACTH水平升高,而给予去氨加压素后只有1例出现类似反应。
去氨加压素能够刺激库欣病患者的ACTH分泌,进而促进皮质醇释放。对于对CRH试验反应可疑的患者、对CRH反应与正常受试者难以区分的患者以及库欣病的术后随访,它可能是一项有用的试验。在一些下丘脑 - 垂体水平皮质醇反馈被消除或减弱的患者中,正常促肾上腺皮质细胞对去氨加压素的敏感性增强。